Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Karyopharm Therapeutics Inc (NASDAQ: KPTI) was $0.96 for the day, down -1.31% from the previous closing price of $0.97. In other words, the price has decreased by -$1.31 from its previous closing price. On the day, 1.75 million shares were traded. KPTI stock price reached its highest trading level at $0.9883 during the session, while it also had its lowest trading level at $0.9253.
Ratios:
Our analysis of KPTI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 3.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.
JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 07 ’24 when PAKIANATHAN DEEPIKA sold 231,548 shares for $0.95 per share. The transaction valued at 220,133 led to the insider holds 0 shares of the business.
PAKIANATHAN DEEPIKA sold 118,452 shares of KPTI for $116,415 on Jun 06 ’24. The Director now owns 2,240 shares after completing the transaction at $0.98 per share. On Jun 05 ’24, another insider, PAKIANATHAN DEEPIKA, who serves as the Director of the company, sold 468,044 shares for $0.96 each. As a result, the insider received 448,480 and left with 3,385 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 119656288 and an Enterprise Value of 273362400. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.85. Its current Enterprise Value per Revenue stands at 1.946 whereas that against EBITDA is -2.07.
Stock Price History:
Over the past 52 weeks, KPTI has reached a high of $2.47, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -16.82%, while the 200-Day Moving Average is calculated to be -12.17%.
Shares Statistics:
KPTI traded an average of 1.25M shares per day over the past three months and 1460270 shares per day over the past ten days. A total of 114.92M shares are outstanding, with a floating share count of 109.04M. Insiders hold about 12.23% of the company’s shares, while institutions hold 60.26% stake in the company. Shares short for KPTI as of 1715731200 were 17559879 with a Short Ratio of 14.02, compared to 1713139200 on 23560996. Therefore, it implies a Short% of Shares Outstanding of 17559879 and a Short% of Float of 15.229999999999999.
